Image

A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma

Assessing side effects and disease activity of Epcoritamab with other medications.

Recruiting
18 years and older
All
Phase 2

B-cell Lymphoma is a rare, fast-growing cancer affecting white blood cells that help fight infections. This study tests the safety of a new drug, epcoritamab, used with other cancer-fighting medicines, in adults with Non-Hodgkin Lymphoma (NHL). Participants are divided into groups and given different treatment combinations. About 622 adults will take part globally. The study involves taking epcoritamab through a needle under the skin (subcutaneous) and other medicines by mouth (oral) or through a vein (intravenous). Treatments occur in cycles of 21, 28, or 56 days, based on the group. The study monitors treatment effects through medical check-ups, blood tests, and questionnaires.

  • Participants must visit the hospital or clinic regularly.
  • Different treatment combinations are based on eligibility.
  • There may be more treatment demands than usual care.
Study details
    Non-Hodgkin Lymphoma

NCT05283720

Genmab

8 March 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.